This should include: regular education of potential referrers about PR and referral pathways; working closely with commissioners ... in chronic respiratory diseases other than COPD. Since the BTS ...

Mepolizumab, a humanized monoclonal antibody that targets interleukin-5 (IL-5), significantly reduced COPD exacerbations in ...

Most people with COPD in the United States are at least 40 years old and have a history of smoking, making smoking cessation a critical part of treatment along with medications, oxygen therapy ...

A robust treatment plan for COPD includes a combination of prescription medication, pulmonary therapies, and healthy lifestyle changes to help relieve symptoms and slow disease progression.

It can affect how you exercise, work, and do other daily activities. The goals of COPD treatment are to reduce symptoms and symptom flare-ups. "This can be done through a combination of lifestyle ...

“In the current treatment landscape for patients experiencing an acute exacerbation with asthma or COPD, there are no approved biologics that can rapidly improve lung function and prevent ...

"In the current treatment landscape for patients experiencing an acute exacerbation with asthma or COPD, there are no approved biologics that can rapidly improve lung function and prevent further ...

belief that Ohtuvayre's bronchodilator and non-steroidal anti-inflammatory activity can re-define the COPD treatment paradigm." The encouraging sales figures come at a time when treatment options ...